PT - JOURNAL ARTICLE AU - MARCHESONI, ANTONIO AU - ATZENI, FABIOLA AU - SPADARO, ANTONIO AU - LUBRANO, ENNIO AU - PROVENZANO, GIUSEPPE AU - CAULI, ALBERTO AU - OLIVIERI, IGNAZIO AU - MELCHIORRE, DANIELA AU - SALVARANI, CARLO AU - SCARPA, RAFFAELE AU - SARZI-PUTTINI, PIERCARLO AU - MONTEPAONE, MONICA AU - PORRU, GIOVANNI AU - D’ANGELO, SALVATORE AU - CATANOSO, MARIAGRAZIA AU - COSTA, LUISA AU - MANARA, MARIA AU - VARISCO, VALENTINA AU - ROTUNNO, LAURA AU - DE LUCIA, ORAZIO AU - DE MARCO, GABRIELE TI - Identification of the Clinical Features Distinguishing Psoriatic Arthritis and Fibromyalgia AID - 10.3899/jrheum.110893 DP - 2012 Apr 01 TA - The Journal of Rheumatology PG - 849--855 VI - 39 IP - 4 4099 - http://www.jrheum.org/content/39/4/849.short 4100 - http://www.jrheum.org/content/39/4/849.full SO - J Rheumatol2012 Apr 01; 39 AB - Objective. To identify the clinical features that can help to distinguish between psoriatic arthritis (PsA) and fibromyalgia (FM). Methods. Our cross-sectional study was carried out in 10 Italian rheumatology centers between January and September 2009, and enrolled all consecutive patients with PsA and FM who agreed to participate. Standard clinical and laboratory data for PsA and FM were collected from all patients. Records were made of somatic symptoms, response to nonsteroidal antiinflammatory drugs (NSAID), self-evaluated pain, general health, disability, and responses to the Fibromyalgia Impact Questionnaire. Data were statistically analyzed by univariate and multivariate analyses, and receiver-operating characteristic curves. The analysis concentrated on the clinical features shared by the 2 conditions. Results. Two hundred sixty-six patients with PsA (mean age 51.7 yrs; disease duration 10.2 yrs) and 120 patients with FM (mean age 50.2 yrs; disease duration 5.6 yrs) were evaluated. Univariate analysis showed that patients with FM had higher mean tender point and enthesitis scores, more somatic symptoms, and responded less to NSAID. Multivariate analysis showed that the presence of ≥ 6 FM-associated symptoms and ≥ 8 tender points was the best predictor of FM. Conclusion. The shared clinical features of PsA and FM that had the greatest discriminating power for FM were the number of FM-associated symptoms and tender point count.